Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021)
Femasys' (FEMY) quarterly Preferred Stock Liabilities came in at $55.3 million in Q1 2021, little changed on a QoQ basis from $55.3 million in Q4 2020.
Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Femasys (FEMY) has 2 years of Preferred Stock Liabilities data on file, last reported at $55.3 million in Q1 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $55.3 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $55.3 million (changed N/A YoY) and the FY2020 annual result came in at $55.3 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $55.3 million in Q1 2021, from $55.3 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $55.3 million in Q2 2020 to a low of $55.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 55.34 Mn |
| Dec 31, 2020 | 55.34 Mn |
| Sep 30, 2020 | 55.34 Mn |
| Jun 30, 2020 | 55.34 Mn |